APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antihistamine Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Antihistamine Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025192 pages

Choose your research edition.

Industry ResearchAntihistamine Drugs Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Antihistamine Drugs Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Antihistamine Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antihistamine Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Antihistamine Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Antihistamine Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Antihistamine Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antihistamine Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antihistamine Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Antihistamine Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antihistamine Drugs include Akorn, Almirall, Boehringer Ingelheim, Meda Consumer Healthcare, AstraZeneca, Bayer, Pfizer, Merck & Co. and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antihistamine Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antihistamine Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antihistamine Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antihistamine Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Antihistamine Drugs Segment by Company

Akorn

Almirall

Boehringer Ingelheim

Meda Consumer Healthcare

AstraZeneca

Bayer

Pfizer

Merck & Co.

Novartis

Johnson & Johnson

Sanofi

Teva Pharmaceutical

Antihistamine Drugs Segment by Type

Prescription-based Antihistamine Drugs

Over-the-counter(OTC) Antihistamine Drugs

Antihistamine Drugs Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Antihistamine Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antihistamine Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antihistamine Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antihistamine Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antihistamine Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antihistamine Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Antihistamine Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Antihistamine Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Antihistamine Drugs Industry Trends Table 2. Antihistamine Drugs Industry Drivers Table 3. Antihistamine Drugs Industry Opportunities and Challenges Table 4. Antihistamine Drugs Industry Restraints Table 5. Global Antihistamine Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Antihistamine Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Antihistamine Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Antihistamine Drugs Sales Market Share by Manufacturers Table 9. Global Antihistamine Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Antihistamine Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Antihistamine Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Antihistamine Drugs Manufacturers, Product Type & Application Table 13. Global Antihistamine Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Antihistamine Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Prescription-based Antihistamine Drugs Table 17. Major Manufacturers of Over-the-counter(OTC) Antihistamine Drugs Table 18. Global Antihistamine Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Antihistamine Drugs Sales by Type (2021-2026) & (K Units) Table 20. Global Antihistamine Drugs Sales by Type (2027-2032) & (K Units) Table 21. Global Antihistamine Drugs Sales Market Share by Type (2021-2026) Table 22. Global Antihistamine Drugs Sales Market Share by Type (2027-2032) Table 23. Global Antihistamine Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Antihistamine Drugs Revenue by Type (2021-2026) & (K Units) Table 25. Global Antihistamine Drugs Revenue by Type (2027-2032) & (K Units) Table 26. Global Antihistamine Drugs Revenue Market Share by Type (2021-2026) Table 27. Global Antihistamine Drugs Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Retail Pharmacies Table 29. Major Manufacturers of Online Pharmacies Table 30. Major Manufacturers of Hospital Pharmacies Table 31. Global Antihistamine Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Antihistamine Drugs Sales by Application (2021-2026) & (K Units) Table 33. Global Antihistamine Drugs Sales by Application (2027-2032) & (K Units) Table 34. Global Antihistamine Drugs Sales Market Share by Application (2021-2026) Table 35. Global Antihistamine Drugs Sales Market Share by Application (2027-2032) Table 36. Global Antihistamine Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Antihistamine Drugs Revenue by Application (2021-2026) & (K Units) Table 38. Global Antihistamine Drugs Revenue by Application (2027-2032) & (K Units) Table 39. Global Antihistamine Drugs Revenue Market Share by Application (2021-2026) Table 40. Global Antihistamine Drugs Revenue Market Share by Application (2027-2032) Table 41. Global Antihistamine Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Antihistamine Drugs Sales by Region (2021-2026) & (K Units) Table 43. Global Antihistamine Drugs Sales Market Share by Region (2021-2026) Table 44. Global Antihistamine Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Antihistamine Drugs Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Antihistamine Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Antihistamine Drugs Sales by Country (2021-2026) & (K Units) Table 48. North America Antihistamine Drugs Sales by Country (2027-2032) & (K Units) Table 49. Europe Antihistamine Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Antihistamine Drugs Sales by Country (2021-2026) & (K Units) Table 51. Europe Antihistamine Drugs Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Antihistamine Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Antihistamine Drugs Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Antihistamine Drugs Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Antihistamine Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Antihistamine Drugs Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Antihistamine Drugs Sales by Country (2027-2032) & (K Units) Table 58. Global Antihistamine Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Antihistamine Drugs Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Antihistamine Drugs Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Antihistamine Drugs Revenue Market Share by Region (2021-2026) Table 62. Global Antihistamine Drugs Revenue Market Share by Region (2027-2032) Table 63. Akorn Company Information Table 64. Akorn Business Overview Table 65. Akorn Antihistamine Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Akorn Antihistamine Drugs Product Portfolio Table 67. Akorn Recent Development Table 68. Almirall Company Information Table 69. Almirall Business Overview Table 70. Almirall Antihistamine Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Almirall Antihistamine Drugs Product Portfolio Table 72. Almirall Recent Development Table 73. Boehringer Ingelheim Company Information Table 74. Boehringer Ingelheim Business Overview Table 75. Boehringer Ingelheim Antihistamine Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Boehringer Ingelheim Antihistamine Drugs Product Portfolio Table 77. Boehringer Ingelheim Recent Development Table 78. Meda Consumer Healthcare Company Information Table 79. Meda Consumer Healthcare Business Overview Table 80. Meda Consumer Healthcare Antihistamine Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Meda Consumer Healthcare Antihistamine Drugs Product Portfolio Table 82. Meda Consumer Healthcare Recent Development Table 83. AstraZeneca Company Information Table 84. AstraZeneca Business Overview Table 85. AstraZeneca Antihistamine Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. AstraZeneca Antihistamine Drugs Product Portfolio Table 87. AstraZeneca Recent Development Table 88. Bayer Company Information Table 89. Bayer Business Overview Table 90. Bayer Antihistamine Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Bayer Antihistamine Drugs Product Portfolio Table 92. Bayer Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Antihistamine Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Pfizer Antihistamine Drugs Product Portfolio Table 97. Pfizer Recent Development Table 98. Merck & Co. Company Information Table 99. Merck & Co. Business Overview Table 100. Merck & Co. Antihistamine Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Merck & Co. Antihistamine Drugs Product Portfolio Table 102. Merck & Co. Recent Development Table 103. Novartis Company Information Table 104. Novartis Business Overview Table 105. Novartis Antihistamine Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Novartis Antihistamine Drugs Product Portfolio Table 107. Novartis Recent Development Table 108. Johnson & Johnson Company Information Table 109. Johnson & Johnson Business Overview Table 110. Johnson & Johnson Antihistamine Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Johnson & Johnson Antihistamine Drugs Product Portfolio Table 112. Johnson & Johnson Recent Development Table 113. Sanofi Company Information Table 114. Sanofi Business Overview Table 115. Sanofi Antihistamine Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Sanofi Antihistamine Drugs Product Portfolio Table 117. Sanofi Recent Development Table 118. Teva Pharmaceutical Company Information Table 119. Teva Pharmaceutical Business Overview Table 120. Teva Pharmaceutical Antihistamine Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Teva Pharmaceutical Antihistamine Drugs Product Portfolio Table 122. Teva Pharmaceutical Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Antihistamine Drugs Distributors List Table 126. Antihistamine Drugs Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Antihistamine Drugs Product Image Figure 2. Global Antihistamine Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antihistamine Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Antihistamine Drugs Sales (2021-2032) & (K Units) Figure 5. Global Antihistamine Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Antihistamine Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Prescription-based Antihistamine Drugs Image Figure 9. Over-the-counter(OTC) Antihistamine Drugs Image Figure 10. Global Antihistamine Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Antihistamine Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Antihistamine Drugs Sales Market Share by Type (2021-2032) Figure 13. Global Antihistamine Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Antihistamine Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Antihistamine Drugs Revenue Market Share by Type (2021-2032) Figure 16. Retail Pharmacies Image Figure 17. Online Pharmacies Image Figure 18. Hospital Pharmacies Image Figure 19. Global Antihistamine Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Antihistamine Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Antihistamine Drugs Sales Market Share by Application (2021-2032) Figure 22. Global Antihistamine Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Antihistamine Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Antihistamine Drugs Revenue Market Share by Application (2021-2032) Figure 25. North America Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Antihistamine Drugs Sales Market Share by Country (2021-2032) Figure 27. U.S. Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Antihistamine Drugs Sales Market Share by Country (2021-2032) Figure 32. Germany Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Antihistamine Drugs Sales Market Share by Country (2021-2032) Figure 39. China Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Antihistamine Drugs Sales Market Share by Country (2021-2032) Figure 47. Brazil Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Antihistamine Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Antihistamine Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Antihistamine Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Antihistamine Drugs Revenue (2021-2032) & (US$ Million) Figure 58. North America Antihistamine Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Antihistamine Drugs Revenue (2021-2032) & (US$ Million) Figure 60. Europe Antihistamine Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Antihistamine Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Antihistamine Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Antihistamine Drugs Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Antihistamine Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Antihistamine Drugs Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Antihistamine Drugs Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription-based Antihistamine Drugs
  • Over-the-counter(OTC) Antihistamine Drugs
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Akorn
  • Almirall
  • Boehringer Ingelheim
  • Meda Consumer Healthcare
  • AstraZeneca
  • Bayer
  • Pfizer
  • Merck & Co.
  • Novartis
  • Johnson & Johnson
  • Sanofi
  • Teva Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antihistamine Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antihistamine Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Antihistamine Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Antihistamine Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Antihistamine Drugs Market Dynamics
  1. 2.1 Antihistamine Drugs Industry Trends
  2. 2.2 Antihistamine Drugs Industry Drivers
  3. 2.3 Antihistamine Drugs Industry Opportunities and Challenges
  4. 2.4 Antihistamine Drugs Industry Restraints
3 Antihistamine Drugs Market by Manufacturers
  1. 3.1 Global Antihistamine Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Antihistamine Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Antihistamine Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Antihistamine Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antihistamine Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Antihistamine Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Antihistamine Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antihistamine Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antihistamine Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antihistamine Drugs Tier 1, Tier 2, and Tier 3
4 Antihistamine Drugs Market by Type
  1. 4.1 Antihistamine Drugs Type Introduction
  2. 4.1.1 Prescription-based Antihistamine Drugs
  3. 4.1.2 Over-the-counter(OTC) Antihistamine Drugs
  4. 4.2 Global Antihistamine Drugs Sales by Type
  5. 4.2.1 Global Antihistamine Drugs Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Antihistamine Drugs Sales by Type (2021-2032)
  7. 4.2.3 Global Antihistamine Drugs Sales Market Share by Type (2021-2032)
  8. 4.3 Global Antihistamine Drugs Revenue by Type
  9. 4.3.1 Global Antihistamine Drugs Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Antihistamine Drugs Revenue by Type (2021-2032)
  11. 4.3.3 Global Antihistamine Drugs Revenue Market Share by Type (2021-2032)
5 Antihistamine Drugs Market by Application
  1. 5.1 Antihistamine Drugs Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Antihistamine Drugs Sales by Application
  6. 5.2.1 Global Antihistamine Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antihistamine Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Antihistamine Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Antihistamine Drugs Revenue by Application
  10. 5.3.1 Global Antihistamine Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Antihistamine Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Antihistamine Drugs Revenue Market Share by Application (2021-2032)
6 Global Antihistamine Drugs Sales by Region
  1. 6.1 Global Antihistamine Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antihistamine Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Antihistamine Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Antihistamine Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antihistamine Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Antihistamine Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Antihistamine Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Antihistamine Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Antihistamine Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Antihistamine Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Antihistamine Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Antihistamine Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Antihistamine Drugs Revenue by Region
  1. 7.1 Global Antihistamine Drugs Revenue by Region
  2. 7.1.1 Global Antihistamine Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Antihistamine Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Antihistamine Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Antihistamine Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Antihistamine Drugs Revenue (2021-2032)
  8. 7.2.2 North America Antihistamine Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Antihistamine Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Antihistamine Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Antihistamine Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Antihistamine Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Antihistamine Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Antihistamine Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Akorn
  2. 8.1.1 Akorn Company Information
  3. 8.1.2 Akorn Business Overview
  4. 8.1.3 Akorn Antihistamine Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Akorn Antihistamine Drugs Product Portfolio
  6. 8.1.5 Akorn Recent Developments
  7. 8.2 Almirall
  8. 8.2.1 Almirall Company Information
  9. 8.2.2 Almirall Business Overview
  10. 8.2.3 Almirall Antihistamine Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Almirall Antihistamine Drugs Product Portfolio
  12. 8.2.5 Almirall Recent Developments
  13. 8.3 Boehringer Ingelheim
  14. 8.3.1 Boehringer Ingelheim Company Information
  15. 8.3.2 Boehringer Ingelheim Business Overview
  16. 8.3.3 Boehringer Ingelheim Antihistamine Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim Antihistamine Drugs Product Portfolio
  18. 8.3.5 Boehringer Ingelheim Recent Developments
  19. 8.4 Meda Consumer Healthcare
  20. 8.4.1 Meda Consumer Healthcare Company Information
  21. 8.4.2 Meda Consumer Healthcare Business Overview
  22. 8.4.3 Meda Consumer Healthcare Antihistamine Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Meda Consumer Healthcare Antihistamine Drugs Product Portfolio
  24. 8.4.5 Meda Consumer Healthcare Recent Developments
  25. 8.5 AstraZeneca
  26. 8.5.1 AstraZeneca Company Information
  27. 8.5.2 AstraZeneca Business Overview
  28. 8.5.3 AstraZeneca Antihistamine Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AstraZeneca Antihistamine Drugs Product Portfolio
  30. 8.5.5 AstraZeneca Recent Developments
  31. 8.6 Bayer
  32. 8.6.1 Bayer Company Information
  33. 8.6.2 Bayer Business Overview
  34. 8.6.3 Bayer Antihistamine Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bayer Antihistamine Drugs Product Portfolio
  36. 8.6.5 Bayer Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Antihistamine Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Antihistamine Drugs Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Merck & Co.
  44. 8.8.1 Merck & Co. Company Information
  45. 8.8.2 Merck & Co. Business Overview
  46. 8.8.3 Merck & Co. Antihistamine Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Merck & Co. Antihistamine Drugs Product Portfolio
  48. 8.8.5 Merck & Co. Recent Developments
  49. 8.9 Novartis
  50. 8.9.1 Novartis Company Information
  51. 8.9.2 Novartis Business Overview
  52. 8.9.3 Novartis Antihistamine Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Novartis Antihistamine Drugs Product Portfolio
  54. 8.9.5 Novartis Recent Developments
  55. 8.10 Johnson & Johnson
  56. 8.10.1 Johnson & Johnson Company Information
  57. 8.10.2 Johnson & Johnson Business Overview
  58. 8.10.3 Johnson & Johnson Antihistamine Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Johnson & Johnson Antihistamine Drugs Product Portfolio
  60. 8.10.5 Johnson & Johnson Recent Developments
  61. 8.11 Sanofi
  62. 8.11.1 Sanofi Company Information
  63. 8.11.2 Sanofi Business Overview
  64. 8.11.3 Sanofi Antihistamine Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sanofi Antihistamine Drugs Product Portfolio
  66. 8.11.5 Sanofi Recent Developments
  67. 8.12 Teva Pharmaceutical
  68. 8.12.1 Teva Pharmaceutical Company Information
  69. 8.12.2 Teva Pharmaceutical Business Overview
  70. 8.12.3 Teva Pharmaceutical Antihistamine Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Teva Pharmaceutical Antihistamine Drugs Product Portfolio
  72. 8.12.5 Teva Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antihistamine Drugs Value Chain Analysis
  2. 9.1.1 Antihistamine Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antihistamine Drugs Production Mode & Process
  6. 9.2 Antihistamine Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antihistamine Drugs Distributors
  9. 9.2.3 Antihistamine Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst